Author： Iyamu Efemwonkiekie W Asakura Toshio
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.13, Iss.6, 2003-06, pp. : 807-813
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Towards gene therapy of sickle cell disease
By Bouhassira E.E. Acharya A.S.
Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 7, 2000-07 ,pp. :
Access to resources
Recommend
Major Challenges for Gene Therapy of Thalassemia and Sickle Cell Disease
Current Gene Therapy, Vol. 10, Iss. 5, 2010-10 ,pp. :
By Yardumian Anne Crawley Charles
Clinical Medicine, Vol. 1, Iss. 6, 2001-11 ,pp. :
Sickle Cell Disease in Children
Drugs, Vol. 72, Iss. 7, 2012-05 ,pp. :
Developing treatment for sickle cell disease
By Brugnara Carlo Steinberg Martin H
Expert Opinion on Investigational Drugs, Vol. 11, Iss. 5, 2002-05 ,pp. :